54 Chapter 2 Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Pelander [200] 2004 Finland 40 Multiple disease groups 4 11 1 Clinical care Pelander [201] 2007 Finland 388 Hospital admission 7 11 3,7 Clinical care Pelander [202] 2009 Finland 388 Hospital admission 7 11 1,3 Intervention development Pelander [203] 2010 Finland 388 Hospital admission 7 11 5 Clinical care Pena [204] 2014 Spain 30 Multiple disease groups 8 14 1 Clinical care Penza-Clyve [205] 2004 United States 36 Asthma 9 15 2 Clinical care Perlman [206] 1987 Canada 25 Multiple disease groups 4 7 1 Clinical care Perrott [207] 2017 United Kingdom 249 Surgery NR NR 7 Clinical care Petronio-Coia [208] 2020 United States 7 Oncology 8 12 1 Clinical care Pflugeisen [209] 2019 United States 7 Oncology 16 34 8 Clinical care Picchietti [210] 2010 United States 33 Restless Legs Syndrome 6 17 1 Intervention development Pichini [211] 2016 Canada 11 Genetic disorders 12 18 1 Clinical care Polkki [212] 1999 Finland 20 Multiple disease groups 7 11 1,8 Clinical care Pope [213] 2018 Australia 15 Acute pain 4 8 1,3 Clinical care Pradel [214] 2001 United States 32 Asthma 7 12 1,3 Clinical care Preti [215] 2011 Italy 6 Multiple disease groups NR NR 1 Clinical care Przybylska [216] 2019 United Kingdom / Australia / United States 9 Hospital admission 3 15 1 Clinical care Radovic [217] 2018 United States 31 Multiple disease groups 13 18 1 Clinical care Ramsdell [218] 2016 United States 10 Trauma 8 16 1 Clinical care Randall [219] 2012 United Kingdom 21 Multiple disease groups 6 12 1,2,4 Clinical care Rasmussen [220] 2017 New Zealand 6 Hospital admission NR NR 1 Clinical care Ray [221] 2017 United States 2 Multiple disease groups 14 21 1 Clinical care Reverend Alister [222] 2007 United Kingdom 5 Multiple disease groups 8 11 8 Clinical care Reynolds [223] 2007 United States 32 Diabetes 12 17 1 Research
RkJQdWJsaXNoZXIy MTk4NDMw